CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Lower Extremity Amputationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04250558
NCT04250558N/ACompleted
CompareCT.gov

Indocyanine Green Fluorescence Guided Imaging in Lower Extremity Amputation Patients

Dartmouth-Hitchcock Medical Center·observational·Posted Jan 31, 2020·Updated Jun 5, 2025

In Brief

An observational study evaluating Lower Extremity Amputation for Trauma Injury. Completed, enrolled 17 participants across 1 site.

Detailed Summary

This is a non-randomized prospective study of 30 patients scheduled to undergo lower extremity amputation (below the knee, through the knee or above the knee) evaluating bone perfusion and viability using indocyanine green (ICG) fluorescence imaging at several steps during surgical procedure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTrauma Injury
CountriesUnited States
CollaboratorsDartmouth College

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 31, 2020
Enrollment StartFeb 1, 2020
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 6.4 years ago

Interventions

Lower Extremity Amputationprocedure

patients 18 years of age or older who will have a planned lower leg (either below knee, through knee, or above knee) amputation surgery are scheduled to undergo a lower extremity amputation (either below knee, through knee or above knee), performed by a participating surgeon or delegate. Provision of informed consent.